Thyroid Diseases: Clinical Trials

1,853 trials for Thyroid Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

838 completed, 373 unknown, 281 recruiting, 100 terminated. 527 Not applicable, 314 Phase 2, 149 Phase 1, 134 Phase 3, 107 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable527Completed 241, Unknown 139, Recruiting 69, Not yet recruiting 29, Terminated 19, Active not recruiting 13, Enrolling by invitation 9, Withdrawn 7, Suspended 1
Phase 2314Completed 144, Recruiting 40, Unknown 36, Active not recruiting 35, Terminated 34, Not yet recruiting 12, Withdrawn 10, Suspended 2, Enrolling by invitation 1
Phase 1149Completed 71, Recruiting 23, Terminated 20, Active not recruiting 16, Unknown 7, Not yet recruiting 6, Withdrawn 6
Phase 3134Completed 55, Recruiting 29, Unknown 18, Active not recruiting 13, Terminated 8, Not yet recruiting 6, Withdrawn 5
Phase 4107Completed 47, Unknown 19, Recruiting 13, Not yet recruiting 11, Terminated 8, Withdrawn 5, Active not recruiting 3, Enrolling by invitation 1
Early Phase 119Recruiting 6, Unknown 5, Active not recruiting 3, Completed 3, Terminated 2

Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mapping Patient Decision-making in Thyroid Cancer
Decision navigation tool - Thyroid Cancer
Not applicableNot yet recruitingUniversity of California, Los Angeles502028-04-012026-07-24
Discontinuation of Low-Dose Levothyroxine in Older Adults With Subclinical Hypothyroidism
Levothyroxine Pill, Placebo - Hypothyroidism
Phase 4Not yet recruitingSpyridoula Maraka1382027-10-012026-08-26
Pre-Clinic Visit Online Education for Thyroid Cancer
THRIVE, ACS "After a Thyroid Cancer Diagnosis" Flyer - Thyroid Cancer
Not applicableNot yet recruitingCedars-Sinai Medical Center602027-08-012026-09-01
Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease
MHB018A injection - Thyroid Eye Disease (TED)
Phase 3Not yet recruitingMinghui Pharmaceutical (Hangzhou) Ltd2192027-07-012026-06-04
Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns
Blood test - Congenital Hypothyroidism
Not yet recruitingUniversity Hospital, Lille16002027-03-012026-05-22
Vitamin E Add-On Therapy, Thyroid Function & Oxidative Stress in Levothyroxine-Treated Hypothyroidism
vitamin E, placebo - Hypothyroidism
Not applicableEnrolling by invitationBangladesh Medical University742027-02-012026-08-25
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
Diagnostic DNA Methylation Signature - Thyroid Gland Nodule
RecruitingCity of Hope Medical Center222027-01-012026-06-02
Impact of Restrictive Diets on Inflammation and Quality of Life in Autoimmune Thyroiditis
Gluten-free, casein-free, low-glycemic-index diet - Thyroid Autoimmune Disease, Hashimoto's Thyroiditis
Not applicableNot yet recruitingUniversity of Barcelona602027-01-012026-11-04
Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer
Dabrafenib, Trametinib, Pembrolizumab - Anaplastic Thyroid Carcinoma, Thyroid Cancer
Phase 2Not yet recruitingWashington University School of Medicine122026-12-312026-10-21
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
Internet-Based Intervention, Interview, Questionnaire Administration - Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm
Not applicableNot yet recruitingUniversity of Michigan Rogel Cancer Center1422026-12-012026-10-15
MYTP01 for Immune-Mediated Diseases
MYTP01, MYTP01 Placebo - IgA Nephropathy, Kidney Transplant Recipients
Not applicableNot yet recruitingZhejiang Provincial People's Hospital1602026-12-012026-11-04
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
68Ga-DOTA-TATE PET Scan, Amino acid infusions, 177Lu-DOTA-EB-TATE - Thyroid Cancer
Phase 1 / Phase 2Not yet recruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)182026-11-102026-11-05
Thyroid-Stimulating Hormone Receptor (TSHR) Blockade With REGN24493 in Adult Participants With Graves' Disease (GD)
REGN24493, Placebo - Graves' Disease
Phase 1Not yet recruitingRegeneron Pharmaceuticals452026-11-022026-10-06
T4/T3 Therapy in Hypothyroidism
Liothyronine (L-T3), Levothyroxine Sodium (LT4) Tablets, Liothyronine (LT3) placebo - Hypothyroidism Primary
Phase 2Not yet recruitingUniversity of Pennsylvania602026-11-012026-08-20
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
Sacituzumab Tirumotecan - Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic
Phase 2Not yet recruitingNational Cancer Centre, Singapore682026-11-012026-07-15
Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO)
Atorvastatin - Graves Disease, Graves Disease (Basedow's Disease)
Phase 2Not yet recruitingRegion Skane5542026-11-012026-10-20
Endotracheal Tube Versus Transcartilage Needle Electrodes for Nerve Monitoring in Thyroid Surgery
Transcartilage needle electrode recording, Endotracheal tube surface electrode recording - Thyroid Diseases, Recurrent Laryngeal Nerve Injury
Not applicableNot yet recruitingMarmara University1002026-11-012026-10-30
Serum Treg/Th17-Related Cytokines and Systemic Inflammatory Indices in Differentiated Thyroid Cancer
Differentiated Thyroid Cancer (DTC), Papillary Thyroid Carcinoma
Not yet recruitingMarmara University902026-11-012026-11-02
Bethesda Classification and Risk Stratification in Differentiated Thyroid Carcinoma
Differentiated Thyroid Carcinoma, Papillary Thyroid Carcinoma
Not yet recruitingAssiut University1002026-10-262026-10-05
AI-Based Wearable Monitoring (Glandy HYPER) for Antithyroid Drug Dose Adjustment in Graves' Disease
Glandy HYPER (AI-based monitoring software), Methimazole - Hyperthyroidism, Graves Disease
Not applicableNot yet recruitingTHYROSCOPE INC.302026-10-202026-10-05

Showing 20 of 1853. Sign in to see all of them.

Narrower conditions

Thyroid Neoplasms (722)  ·  Graves Ophthalmopathy (197)  ·  Hypothyroidism (195)  ·  Thyroid Nodule (186)  ·  Thyroid Cancer, Papillary (185)  ·  Graves Disease (160)  ·  Hyperthyroidism (110)  ·  Neoplasms (79)  ·  Breast Neoplasms (76)  ·  Head and Neck Neoplasms (70)  ·  Adenocarcinoma, Follicular (62)  ·  Goiter (61)  ·  Melanoma (60)  ·  Carcinoma, Non-Small-Cell Lung (57)

Broader conditions

Endocrine System Diseases (1832)  ·  Neoplasms by Site (962)  ·  Endocrine Gland Neoplasms (935)  ·  Neoplasms (918)  ·  Head and Neck Neoplasms (880)  ·  Immune System Diseases (436)  ·  Autoimmune Diseases (374)  ·  Neoplasms by Histologic Type (352)  ·  Goiter (329)  ·  Eye Diseases (325)  ·  Orbital Diseases (318)  ·  Neoplasms, Glandular and Epithelial (311)  ·  Exophthalmos (304)  ·  Hyperthyroidism (291)

Interventions

Thyroxine (90)  ·  Thyroidectomy (31)  ·  Iodine-131 (30)  ·  Triiodothyronine (25)  ·  Methimazole (24)  ·  Methylprednisolone (22)  ·  Magnetic Resonance Spectroscopy (21)  ·  lenvatinib (20)  ·  Blood Specimen Collection (17)  ·  Thyrotropin Alfa (17)  ·  teprotumumab (15)  ·  trametinib (15)  ·  Saline Solution (14)  ·  pembrolizumab (14)  ·  Sorafenib (13)

Sponsors

Assiut University (45)  ·  National Cancer Institute (NCI) (45)  ·  Memorial Sloan Kettering Cancer Center (26)  ·  M.D. Anderson Cancer Center (21)  ·  National Taiwan University Hospital (21)  ·  Fujian Medical University (17)  ·  Sun Yat-sen University (17)  ·  Amgen (16)  ·  Fudan University (16)  ·  Mayo Clinic (15)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (15)  ·  Yonsei University (15)  ·  Seoul National University Hospital (14)  ·  University of Pisa (14)  ·  Chinese PLA General Hospital (12)

Countries

United States (511)  ·  China (303)  ·  Italy (134)  ·  France (127)  ·  South Korea (97)  ·  Turkey (Türkiye) (78)  ·  Spain (76)  ·  Germany (73)  ·  United Kingdom (70)  ·  Canada (68)  ·  Denmark (62)  ·  Poland (53)  ·  Egypt (51)  ·  Taiwan (51)  ·  Australia (46)

Top investigators

Marcin Barczynski, MD, PhD (7)  ·  Joanna Klubo-Gwiezdzinska, M.D. (6)  ·  Yukun Luo (5)  ·  Kiyohiko Mabuchi, M.D. (4)  ·  Naris Nilubol, M.D. (4)  ·  Yunwei Wei (4)  ·  Alan Ho, MD, PhD (3)

Results publications

PMID 37934000, PMID 27797318, PMID 40341199, PMID 40668552, PMID 18299459, PMID 19556464, PMID 19850691, PMID 22402975, PMID 25209242, PMID 26462967, PMID 27240885, PMID 28487349, PMID 29343557, PMID 31838007, PMID 32612576, PMID 33570641, PMID 33720068, PMID 33768488, PMID 36657661, PMID 37171634, PMID 37786277, PMID 37816266, PMID 40086048, PMID 40844370, PMID 41066062, PMID 10427152, PMID 10517721, PMID 10634372, PMID 10683005, PMID 10782451, PMID 10873993, PMID 11119728, PMID 11129808, PMID 11172193, PMID 11239487, PMID 11334386, PMID 11442004, PMID 11535445, PMID 11580992, PMID 11875733, PMID 11879213, PMID 11932302, PMID 12050214, PMID 12225640, PMID 12390993, PMID 12541136, PMID 12608932, PMID 12656658, PMID 12660642, PMID 12727961

NIH funding

2023 (10), 2025 (8), 2015 (7), 2016 (5), P30CA015083 (5), 2017 (4), 2019 (4), N01CM62207 (4), 2005 (3), 2014 (3), N01CM00099 (3), N01CM62201 (3), N01CM62206 (3), P30CA008748 (3), P30CA016672 (3)